Advertisement
Loading...

Cannara Biotech Inc.

LOVFF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.23
$-0.01(-0.81%)
U.S. Market is Open • 13:24
Advertisement

Cannara Biotech Inc. (LOVFF) Stock Overview

Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap123.5M
P/E Ratio16.34
EPS (TTM)$0.08
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$1.31
3 Months$1.38
1 Year Target$1.95

LOVFF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVFF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.34 and a market capitalization of 123.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.65%
5-Day Change
-0.65%
1-Month Change
-4.50%
3-Month Change
-8.74%
6-Month Change
0.16%
Year-to-Date (YTD) Change
-2.99%
1-Year Change
41.61%
3-Year Change
93.25%
5-Year Change
15.14%
All-Time (Max) Change
-31.17%

Contact Information

https://cannara.ca
514-543-4200
333 Decarie Blvd., Saint-Laurent, QC, H4N 3M9

Company Facts

461 Employees
IPO DateJan 18, 2019
CountryCA
Actively Trading

Frequently Asked Questions